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CASE REPORT
Helicobacter cinaedi bacteraemia secondary 
to enterocolitis in an immunocompetent patient
Sofie Larsen Rasmussen1, Iben Ørsted2, Irene Harder Tarpgaard1 and Hans Linde Nielsen1,3*  
Abstract 
Background: Helicobacter cinaedi are motile, gram-negative spiral rods with a natural reservoir in the intestinal tract 
of hamsters and rhesus monkeys. In humans, H. cinaedi has been reported in different human infections like fever, 
abdominal pain, gastroenteritis, proctitis, diarrhoea, erysipelas, cellulitis, arthritis, and neonatal meningitis typically 
diagnosed by positive blood cultures. Even though H. cinaedi has been detected from human blood and stool the 
entry of H. cinaedi into the blood stream was undocumented until quite recently. The use of pulse-field gel electro-
phoresis (PFGE) demonstrated that stool- and blood-derived H. cinaedi strains were consistent.
Case presentation: Here, we describe a rare Danish case of H. cinaedi bacteraemia in an immunocompetent 44-year-
old male with diarrhoea. We isolated H. cinaedi from a blood culture taken at admission, and from a FecalSwab taken 
at day six despite ongoing antibiotic therapy. Next, we made a genetic comparison of both isolates by use of Multi-
locus sequence typing (MLST)- and Single nucleotide polymorphism (SNP)-analysis. The two isolates were identical 
with zero SNPs and by use of MLST the isolate was identified as a novel ST20, confirming previous data of the intesti-
nal tract as a route of H. cinaedi bacteraemia. The results of our AST showed a resistance pattern with higher MICs for 
ciprofloxacin and clarithromycin than for ampicillin, amoxicillin, gentamicin, and imipenem. The patient was cured 
with targeted therapy with pivampicillin; however, the primary source of transmission was unknown.
Conclusions: In conclusion, this case of H. cinaedi bacteraemia secondary to enterocolitis in an immunocompetent 
patient provide clear evidence that one route of infection occurs through translocation from the intestinal tract to the 
bloodstream. Helicobacter cinaedi from blood and faeces were identical with a novel ST20, resistant to ciprofloxacin 
and clarithromycin however, the patient was cured with oral pivampicillin.
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Background
Helicobacter cinaedi was originally described as Campy-
lobacter cinaedi by Totten et  al. in 1985 however, six 
year later it was reclassified into genus Helicobacter 
by Vandamme et  al. [1, 2]. These organisms are motile, 
gram-negative spiral rods which have been isolated from 
different domestic animals including dogs, cats and foxes 
[3]. However, the only natural reservoir of H. cinaedi is 
the intestinal tract of hamsters and rhesus monkeys [3, 
4].
In humans, H. cinaedi was first isolated from the rectal 
cultures of HIV-positive, homosexual men with procti-
tis, proctocolitis, and enteritis [5]. It was initially consid-
ered an opportunistic pathogen that caused disease in 
immunocompromised patients however in recent years 
infections in immunocompetent patients have also been 
reported [6]. Most H. cinaedi infections with symptoms 
such as fever, abdominal pain, gastroenteritis, proctitis, 
diarrhoea, erysipelas, cellulitis, arthritis and neonatal 
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Even though H. cinaedi was detected in both blood 
and stool cultures the entry of H. cinaedi into the blood 
stream was undocumented for decades. However, in 
2018 Araoka et al. demonstrated by use of pulse-field gel 
electrophoresis (PFGE) that stool- and blood-derived H. 
cinaedi strains were consistent in nine Japanese patients 
giving first evidence of translocation from the intestinal 
tract as one of the routes that leads to H. cinaedi bacte-
raemia [9].
Here, we describe a rare Danish case of H. cinaedi 
bacteraemia in an immunocompetent patient with diar-
rhoea. We isolated H. cinaedi from blood and faeces 
and made a genetic comparison of the isolates by use of 
Multi-locus sequence typing (MLST)- and Single nucleo-
tide polymorphism (SNP)-analysis and found that they 
were identical, confirming previous data of the intestinal 
tract as a route of H. cinaedi bacteraemia [9].
Case presentation
A 44-year-old male with a family history of polycys-
tic kidney disease though otherwise healthy with no 
medical record was admitted to Aalborg University 
Hospital on suspicion of chronic kidney disease. The 
patient presented with nausea and diarrhoea with five 
lose watery stools a day for two weeks, and a sudden 
onset of fever, chills, flank and lower back pain, and 
dark urine. He did not report any bloody diarrhoea, nor 
dysuria, polyuria, urgency or haematuria. His tempera-
ture was 39.8  °C however, the physical examination and 
his vital parameters were normal. Laboratory findings 
showed leucocytosis with a WBC-count of 17.5 ×  109/L, 
an elevated CRP of 90  mg/L, and a mild hyponatremia 
(p-sodium: 136mmol/L) and hypokalaemia (p-potassium: 
3.4 mmol/L) however, there was a normal p-creatinine of 
80  µmol/L. Urine and blood culture was obtained, and 
on suspicion of urinary tract infection standard empiric 
antibiotic therapy was initiated with intravenous ampi-
cillin 2 g every 6 h, and gentamicin 5 mg/kg once daily. 
After two days the patient was afebrile nevertheless, CRP 
was further elevated to 301. Therefore, the antibiotic 
therapy was changed to intravenous mecillinam (amdi-
nocillin) 1 g every 8 h. The chest x-ray was normal how-
ever, ultrasound showed multiple cysts in the liver and in 
both kidneys however, no sign of hydronephrosis.
Urine culture was negative. On day six there was a 
positive blood culture with growth of Gram-negative 
spiral-shaped rods and on preliminary suspicion of 
Campylobacter bacteraemia oral roxithromycin 150  mg 
twice daily was initiated. In addition, a stool culture 
was sent to the laboratory. Seven days after hospitaliza-
tion he was afebrile, CRP had dropped to 133 mg/L. The 
diarrhoea symptoms were declining, and still he had 
no urinary symptoms, so he was discharged with oral 
pivmecillinam 400  mg every 8  h and roxithromycin. At 
day 10 the patient was seen in an outpatient setting and 
he reported ongoing diarrhoea and with a simultaneous 
identification of H. cinaedi in blood and stools antibiotic 
therapy was changed to oral pivampicillin 500 mg every 
8 h for seven days. At day 17, he no longer had diarrhoea 
and CRP was normalised at 5.7 mg/L. The patient owned 
a dog, and had no close contact to other animals and was 
immunocompetent.
Investigations
A standard blood culture was obtained upon submission 
(Two BD BACTEC™ Plus Aerobic medium and one BD 
BACTEC™ Lytic Anaerobic medium glass culture vials) 
incubated in the BACTEC FX Top instrument (Becton 
Dickinson AB, Stockholm, Sweden). After six days of 
incubation there was growth in the two aerobic bottles 
(Time to detection (TTD): 141.3 and 143.6  h, respec-
tively) of motile, Gram-negative, spiral-shaped rods. Sub-
cultivation was performed on 5 % yeast-enriched horse 
blood agar plates (SSI Diagnostica, Hillerød, Denmark) at 
37  °C in a hydrogen-enriched microaerobic atmosphere 
(6%  O2, 6%  CO2, 6%  H2, and 82%  N2) and examined after 
48 h. The isolate was urease negative though oxidase and 
catalase positive, and final identification of H. cinaedi was 
performed by use of the matrix-assisted laser desorption 
ionization–time of flight (MALDI Biotyper 3.1, Bruker 
Daltonics Microflex LT, MBT 6903 MSP Library) with a 
score of 2.060.
No clinical breakpoints exist for H. cinaedi, however, 
antibiotic susceptibility testing (AST) was performed by 
use of McFarland standard 1.0 on Mueller-Hinton agar 
for fastidious organisms (MH supplemented with 5% 
defibrinated horse blood and 20 mg/L β-NAD) and Etest 
(BioMérieux, Marcy l’Etoile, France) in a microaerobic 
atmosphere. The isolate showed low minimum inhibi-
tory concentrations (MICs) to ampicillin (MIC: 2 mg/L), 
amoxicillin (MIC: 4 mg/L), imipenem (MIC: 0.032 mg/L) 
and gentamicin (MIC: 0.25  mg/L) and resistant to cip-
rofloxacin (MIC: >  32  mg/L) and clarithromycin (MIC: 
>  256  mg/L). For mecillinam (no etest available) we 
included disc diffusion (disc content, 10 µg), showing an 
inhibition zone of 18  mm, however, we were unable to 
interpret this result.
 After the positive blood culture on day 6 a FecalSwab 
(COPAN ITALIA, Brescia, Italy) was sent to the lab-
oratory. The sample was negative for Aeromonas, 
Campylobacter, Salmonella, Shigella, Vibrio, Yersinia 
enterocolitica by routine culture methods and Clostridi-
oides difficile toxins by use of the Xpert C. difficile 
BT (Cepheid). However, 0.5 ml liquid media from the 
FecalSwab were incubated by use of a polycarbonate fil-
ter method on a 5% yeast-enriched blood agar plate (SSI 
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Diagnostica, Hillerød, Denmark) as described elsewhere 
[10]. After 48 h at 37  °C in a hydrogen-enriched micro-
aerobic atmosphere, there was growth of H. cinaedi, 
identified with a MALDI log-score of 2.080.
Next, we performed genome sequencing of both 
isolates to investigate whether the H. cinaedi in fae-
ces and blood were identical. We used the Illumina 
MiSeq instrument producing 2 × 300-bp paired-end 
reads by using Nextera XT library preparation kit (Illu-
mina Denmark ApS, Copenhagen, Denmark). Reads 
were assembled using CLC Genomics Workbench (ver-
sion 11) (QIAGEN Bioinformatics, Aarhus, Denmark) 
into contigs (n = 74 + n = 72 ≥ 1  kb, respectively), N50 
(89,940 + 96,798, respectively), total sequence length 
2,406,086 + 2,403,138  bp, respectively, and with a G + C 
content of 38.4 %. To subtype our strains and identify 
sequence type (ST) we used the H. cinaedi Multilocus 
Sequence Typing (MLST) database [11]. Both isolates 
were classified as a novel ST20 (allelic profile, 23S_rRNA: 
5, ppa: 7, aspA: 5, aroE: 7, atpA: 3, tkt: 5, cdtB: 3) (The 
blood isolate, AAUH 190,263, was uploaded to: https:// 
pubml st. org/). Next, we used the CSI Phylogeny v1.4 
pipeline (with default-settings) for SNP-calling between 
isolates [12], which showed 0 SNPs, giving clear evidence 
of identical strains and a translocation of H. cinaedi from 
the intestinal tract into the bloodstream.
Discussion and conclusions
This is the first Danish case of H. cinaedi bacteraemia 
with documented evidence of translocation from the 
intestinal tract in an immunocompetent patient. We iso-
lated H. cinaedi from blood in two aerobic BACTEC bot-
tles after six days of incubation, and faeces by use of the 
polycarbonate filtration technique. By use of MLST and 
SNP-analyses we identified the two isolates as a single 
(zero SNPs) ST20. Araoka et al. evaluated the TTD for H. 
cinaedi in the BACTEC system and found median time 
of 5 days (range, 2 to 12 days), and all H. cinaedi strains 
(126 positive sets) were detected in aerobic bottles only 
[7]. The blood cultures in our laboratory are routinely 
incubated for 7 days, which theoretically should be suf-
ficient to find 87% of ‘true’ H. cinaedi-positive blood cul-
tures [7]. In comparison, Kawamura et  al. also reported 
positive results with the VersaTREK systems providing 
excellent growth ability for H. cinaedi [8] however, to 
our knowledge the VersaTREK system is not available in 
Denmark.
Helicobacter cinaedi infection seems very uncom-
mon in Denmark, with only two previous cases: One 
case with blood stream infection secondary to cellulitis, 
and one case with septic arthritis, respectively [13, 14]. 
Nielsen et  al. investigated 5.963 diarrheic stool samples 
from 4.094 patients and identified two isolates of H. 
cinaedi by use of the polycarbonate filter method [10]. 
Thus, H. cinaedi is uncommon in Danish stool samples. 
In contrast, H. cinaedi has been isolated from diarrheic 
stool samples and blood cultures of paediatric patients 
in South Africa [15], and it has been reported that H. 
cinaedi constitutes approximately 2.2% of positive blood 
cultures in Japan [7]. Recurrent bacteraemia has also 
been described with cellulitis as the most frequent clini-
cal symptom [16–19]. The cause of the substantial dif-
ference in occurrence of H. cinaedi infection between 
Denmark and Japan is unknown.
Through genome sequencing we confirmed that the 
isolates of H. cinaedi from stool and blood were identical 
by MLST-profile and zero SNPs. Previously, MLST were 
used to identify H. cinaedi STs causing nosocomial out-
breaks in Japanese hospitals, whereas some isolates were 
non-typeable by Pulsefield gel electrophoresis PFGE [11]. 
In the MLST-database the majority of H. cinaedi isolates 
(n = 70 per 2021-02-10) are from Japan (89%), USA or 
Australia, so the designation of a ‘novel’ ST is not surpris-
ing. Our isolate is also the single European H. cinaedi iso-
late in the database.
Until recently, the entrance of H. cinaedi into the blood 
stream were more or less undocumented and Kawamura 
et al. stated the importance of pursuing the route of infec-
tion [8]. In 2018, Araoka et al. described PFGE typing to 
confirm clonality of the faeces and blood isolates from 
nine immunocompromised patients with fever and cellu-
litis, delivering the first evidence of bacterial translocation 
from the intestinal tract as a route of H. cinaedi bacterae-
mia [9]. Our patient did not show any signs of cellulitis in 
addition to diarrhoea, nor was he immunocompromised, 
whereas the nine patients described by Araoka et al. were 
treated with either steroids or anticancer chemotherapy 
[9]. Interestingly, the same study group identified antican-
cer chemotherapy and systemic steroids as independent 
risk factors for recurrent H. cinaedi bacteraemia [16], a 
condition that apparently seems rare outside of Japan. Pre-
vious case reports have also described hepatic and kidney 
cyst infection with bacteraemia caused H. cinaedi [20–22], 
however the radiological imaging showed no sign of infec-
tion in the cysts in the presented case.
Helicobacter cinaedi is not known to normally colonize 
the intestines of humans, and it has been proposed that 
infection might develop through zoonotic transmission [8], 
or through nosocomial spread among immunocompro-
mised patients during hospitalization [23, 24]. Our patient 
owned a dog, and had no close contact with other animals, 
so the primary source of transmission remains unknown. 
Kiehlbauch et  al. showed that H. cinaedi isolates from 
human, dog, and hamster formed distinct ribotype pat-
tern [25], and two decades later Kawamura et al. found that 
isolates from dogs which had been identified as H. cinaedi 
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were different from human H. cinaedi isolates by whole-
genome in silico DNA similarities and therefore re-classi-
fied as the new Helicobacter canicola [26].
There is no clinical breakpoints nor recommended guide-
line for the choice or duration of antibiotic therapy for H. 
cinaedi infection. Recently, Nukui et  al. suggested a two-
week antibiotic therapy to prevent recurrence of H cinaedi 
bacteremia [27]. The results of our AST were in coherence 
with previously reported resistance patterns of H. cinaedi 
with higher MICs for ciprofloxacin and clarithromycin 
than for ampicillin, amoxicillin, gentamicin, and imipenem 
[8, 27]. After admission, the patient responded on empiric 
therapy with ampicillin and gentamicin and became afe-
brile. However, the empiric antibiotic regime was later 
changed to intravenous mecillinam, and despite this ther-
apy H. cinaedi could be isolated from a FecalSwab taken 
six days after admission. Pivmecillinam and roxithromycin 
had also no clinical effect as diarrheal symptoms resided. 
However, a change to pivampicillin stopped the diarrheal 
symptoms and CRP normalized, and to our knowledge the 
patient has not been hospitalized since.
In conclusion, this case of H. cinaedi bacteraemia sec-
ondary to enterocolitis in an immunocompetent patient 
provide clear evidence that one route of infection occurs 
through translocation from the intestinal tract to the 
bloodstream. Helicobacter cinaedi from blood and faeces 
were identical with a ‘novel’ ST20, resistant to ciprofloxa-
cin and clarithromycin however, the patient was cured 
with oral pivampicillin.
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